Cargando…
Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display
Insulin-degrading enzyme (IDE) is an atypical zinc-metalloendopeptidase that hydrolyzes insulin and other intermediate-sized peptide hormones, many of which are implicated in skin health and wound healing. Pharmacological inhibitors of IDE administered internally have been shown to slow the breakdow...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814047/ https://www.ncbi.nlm.nih.gov/pubmed/29447281 http://dx.doi.org/10.1371/journal.pone.0193101 |
_version_ | 1783300276545912832 |
---|---|
author | Suire, Caitlin N. Nainar, Sarah Fazio, Michael Kreutzer, Adam G. Paymozd-Yazdi, Tara Topper, Caitlyn L. Thompson, Caroline R. Leissring, Malcolm A. |
author_facet | Suire, Caitlin N. Nainar, Sarah Fazio, Michael Kreutzer, Adam G. Paymozd-Yazdi, Tara Topper, Caitlyn L. Thompson, Caroline R. Leissring, Malcolm A. |
author_sort | Suire, Caitlin N. |
collection | PubMed |
description | Insulin-degrading enzyme (IDE) is an atypical zinc-metalloendopeptidase that hydrolyzes insulin and other intermediate-sized peptide hormones, many of which are implicated in skin health and wound healing. Pharmacological inhibitors of IDE administered internally have been shown to slow the breakdown of insulin and thereby potentiate insulin action. Given the importance of insulin and other IDE substrates for a variety of dermatological processes, pharmacological inhibitors of IDE suitable for topical applications would be expected to hold significant therapeutic and cosmetic potential. Existing IDE inhibitors, however, are prohibitively expensive, difficult to synthesize and of undetermined toxicity. Here we used phage display to discover novel peptidic inhibitors of IDE, which were subsequently characterized in vitro and in cell culture assays. Among several peptide sequences tested, a cyclic dodecapeptide dubbed P12-3A was found to potently inhibit the degradation of insulin (K(i) = 2.5 ± 0.31 μM) and other substrates by IDE, while also being resistant to degradation, stable in biological milieu, and highly selective for IDE. In cell culture, P12-3A was shown to potentiate several insulin-induced processes, including the transcription, translation and secretion of alpha-1 type I collagen in primary murine skin fibroblasts, and the migration of keratinocytes in a scratch wound migration assay. By virtue of its potency, stability, specificity for IDE, low cost of synthesis, and demonstrated ability to potentiate insulin-induced processes involved in wound healing and skin health, P12-3A holds significant therapeutic and cosmetic potential for topical applications. |
format | Online Article Text |
id | pubmed-5814047 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-58140472018-03-02 Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display Suire, Caitlin N. Nainar, Sarah Fazio, Michael Kreutzer, Adam G. Paymozd-Yazdi, Tara Topper, Caitlyn L. Thompson, Caroline R. Leissring, Malcolm A. PLoS One Research Article Insulin-degrading enzyme (IDE) is an atypical zinc-metalloendopeptidase that hydrolyzes insulin and other intermediate-sized peptide hormones, many of which are implicated in skin health and wound healing. Pharmacological inhibitors of IDE administered internally have been shown to slow the breakdown of insulin and thereby potentiate insulin action. Given the importance of insulin and other IDE substrates for a variety of dermatological processes, pharmacological inhibitors of IDE suitable for topical applications would be expected to hold significant therapeutic and cosmetic potential. Existing IDE inhibitors, however, are prohibitively expensive, difficult to synthesize and of undetermined toxicity. Here we used phage display to discover novel peptidic inhibitors of IDE, which were subsequently characterized in vitro and in cell culture assays. Among several peptide sequences tested, a cyclic dodecapeptide dubbed P12-3A was found to potently inhibit the degradation of insulin (K(i) = 2.5 ± 0.31 μM) and other substrates by IDE, while also being resistant to degradation, stable in biological milieu, and highly selective for IDE. In cell culture, P12-3A was shown to potentiate several insulin-induced processes, including the transcription, translation and secretion of alpha-1 type I collagen in primary murine skin fibroblasts, and the migration of keratinocytes in a scratch wound migration assay. By virtue of its potency, stability, specificity for IDE, low cost of synthesis, and demonstrated ability to potentiate insulin-induced processes involved in wound healing and skin health, P12-3A holds significant therapeutic and cosmetic potential for topical applications. Public Library of Science 2018-02-15 /pmc/articles/PMC5814047/ /pubmed/29447281 http://dx.doi.org/10.1371/journal.pone.0193101 Text en © 2018 Suire et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Suire, Caitlin N. Nainar, Sarah Fazio, Michael Kreutzer, Adam G. Paymozd-Yazdi, Tara Topper, Caitlyn L. Thompson, Caroline R. Leissring, Malcolm A. Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display |
title | Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display |
title_full | Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display |
title_fullStr | Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display |
title_full_unstemmed | Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display |
title_short | Peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display |
title_sort | peptidic inhibitors of insulin-degrading enzyme with potential for dermatological applications discovered via phage display |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814047/ https://www.ncbi.nlm.nih.gov/pubmed/29447281 http://dx.doi.org/10.1371/journal.pone.0193101 |
work_keys_str_mv | AT suirecaitlinn peptidicinhibitorsofinsulindegradingenzymewithpotentialfordermatologicalapplicationsdiscoveredviaphagedisplay AT nainarsarah peptidicinhibitorsofinsulindegradingenzymewithpotentialfordermatologicalapplicationsdiscoveredviaphagedisplay AT faziomichael peptidicinhibitorsofinsulindegradingenzymewithpotentialfordermatologicalapplicationsdiscoveredviaphagedisplay AT kreutzeradamg peptidicinhibitorsofinsulindegradingenzymewithpotentialfordermatologicalapplicationsdiscoveredviaphagedisplay AT paymozdyazditara peptidicinhibitorsofinsulindegradingenzymewithpotentialfordermatologicalapplicationsdiscoveredviaphagedisplay AT toppercaitlynl peptidicinhibitorsofinsulindegradingenzymewithpotentialfordermatologicalapplicationsdiscoveredviaphagedisplay AT thompsoncaroliner peptidicinhibitorsofinsulindegradingenzymewithpotentialfordermatologicalapplicationsdiscoveredviaphagedisplay AT leissringmalcolma peptidicinhibitorsofinsulindegradingenzymewithpotentialfordermatologicalapplicationsdiscoveredviaphagedisplay |